CHINA PHARMA HOLDINGS, INC. financial data

Symbol
CPHI on NYSE
Location
Hainan Province, China
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 12 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 51% %
Quick Ratio 34% %
Debt-to-equity 99% %
Return On Equity -43% % 32%
Return On Assets -22% %
Operating Margin -80% % 3.3%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 5,022,002 shares -74%
Common Stock, Shares, Outstanding 3,261,911 shares -82%
Entity Public Float $4,290,693 USD 10%
Common Stock, Value, Issued $5,022 USD -72%
Weighted Average Number of Shares Outstanding, Basic 3,874,085 shares 124%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $4,052,266 USD -27%
Cost of Revenue $4,495,580 USD -40%
Research and Development Expense $91,407 USD -79%
General and Administrative Expense $2,232,216 USD 38%
Operating Income (Loss) $3,234,919 USD 29%
Nonoperating Income (Expense) $45,066 USD 29%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $3,189,853 USD 33%
Net Income (Loss) Attributable to Parent $3,189,853 USD 33%
Earnings Per Share, Basic 1 USD/shares 74%
Earnings Per Share, Diluted 1 USD/shares 74%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $267,625 USD -62%
Accounts Receivable, after Allowance for Credit Loss, Current $224,638 USD -33%
Inventory, Net $1,649,682 USD -34%
Assets, Current $2,329,427 USD -38%
Property, Plant and Equipment, Net $4,502,479 USD -15%
Operating Lease, Right-of-Use Asset $197,851 USD 236%
Intangible Assets, Net (Excluding Goodwill) $8,775,036 USD 101%
Assets $15,804,793 USD 17%
Accrued Liabilities, Current $170,426 USD 106%
Contract with Customer, Liability, Current $120,912 USD 385%
Liabilities, Current $6,622,806 USD 39%
Deferred Income Tax Liabilities, Net $739,733 USD -1.4%
Operating Lease, Liability, Noncurrent $128,257 USD
Liabilities $7,490,796 USD 8%
Accumulated Other Comprehensive Income (Loss), Net of Tax $11,404,756 USD -1%
Retained Earnings (Accumulated Deficit) $45,992,100 USD -7.5%
Stockholders' Equity Attributable to Parent $8,313,997 USD 27%
Liabilities and Equity $15,804,793 USD 17%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $57,822 USD 90%
Net Cash Provided by (Used in) Financing Activities $70,033 USD -1121%
Net Cash Provided by (Used in) Investing Activities $80,965 USD
Common Stock, Shares Authorized 500,000,000 shares 0%
Common Stock, Shares, Issued 3,261,911 shares -82%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $214,191 USD 63%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $267,625 USD -63%
Interest Paid, Excluding Capitalized Interest, Operating Activities $21,241 USD -7.4%
Deferred Tax Assets, Valuation Allowance $21,702,958 USD 18%
Deferred Tax Assets, Gross $21,702,958 USD 18%
Operating Lease, Liability $198,583 USD 230%
Depreciation $897,378 USD -62%
Payments to Acquire Property, Plant, and Equipment $58,324 USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $3,307,712 USD 27%
Lessee, Operating Lease, Liability, to be Paid $207,135 USD 239%
Property, Plant and Equipment, Gross $37,472,621 USD -1.2%
Operating Lease, Liability, Current $70,326 USD 17%
Lessee, Operating Lease, Liability, to be Paid, Year Two $56,491 USD
Lessee, Operating Lease, Liability, to be Paid, Year One $75,322 USD 23%
Operating Lease, Weighted Average Discount Rate, Percent 0.04 pure
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $8,552 USD 857%
Preferred Stock, Shares Authorized 5,000,000 shares 0%
Operating Lease, Payments $77,142 USD -9.2%
Additional Paid in Capital $43,076,319 USD 14%
Amortization of Intangible Assets $653,432 USD 78%
Depreciation, Depletion and Amortization $329,313 USD -55%
Deferred Tax Assets, Net of Valuation Allowance $22,700,000 USD
Interest Expense $27,166 USD -0.66%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%